or Try an Advanced Search...

    Technical Analysis for AWH - Aspira Women's Health Inc.

    Grade Last Price % Change Price Change
    F 0.70 -3.56% -0.03
    AWH closed up 2.46 percent on Wednesday, November 20, 2024, on 53 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AWH trend table...
    Date Alert Name Type % Chg
    Lizard Bullish Bullish Day Trade Setup -3.56%
    Doji - Bullish? Reversal -3.56%
    Lower Bollinger Band Walk Weakness -3.56%
    New 52 Week Low Weakness -3.56%
    Wide Bands Range Expansion -3.56%
    Lower Bollinger Band Touch Weakness -3.56%
    Oversold Stochastic Weakness -3.56%
    New 52 Week Closing Low Bearish -1.19%
    Stochastic Buy Signal Bullish -1.19%
    Lower Bollinger Band Walk Weakness -1.19%
    Older End-of-Day Signals for AWH ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 2 hours ago
    Lizard Bullish Entry about 2 hours ago
    Rose Above Previous Day's High about 2 hours ago
    Down 3% about 2 hours ago
    Down 2 % about 2 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AWH Chart by TradingView
    Basic chart:

    Profile

    Aspira Women’s Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology

    Is AWH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Earnings Scheduled For November 14, 2024
    Nov 7 Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®
    Oct 15 Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch®
    Sep 10 Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass
    Sep 6 Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Sep 5 Aspira Women’s Health Selected as a Spoke for the Investor Catalyst Hub
    Aug 27 Aspira Women’s Health Partners with Dorsata to Create New Clinical Workflow Tool for Adnexal Masses
    Aug 14 Aspira Women's Health Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Aug 5 Aspira Women’s Health’s Announces a Poster Presentation at the 27th Annual National Association of Nurse Practitioners in Women’s Health (NPWH) Women’s Healthcare Conference
    Jul 29 Aspira Women’s Health Appoints Mr. John Ragard to its Board of Directors
    See more AWH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.65
    52 Week Low 0.6679
    Average Volume 96,189
    200-Day Moving Average 2.06
    50-Day Moving Average 0.84
    20-Day Moving Average 0.85
    10-Day Moving Average 0.79
    Average True Range 0.09
    RSI (14) 33.33
    ADX 20.9
    +DI 13.19
    -DI 19.79
    Chandelier Exit (Long, 3 ATRs) 1.10
    Chandelier Exit (Short, 3 ATRs) 0.94
    Upper Bollinger Bands 1.01
    Lower Bollinger Band 0.70
    Percent B (%b) 0.11
    BandWidth 36.60
    MACD Line -0.04
    MACD Signal Line -0.02
    MACD Histogram -0.0175
    Fundamentals Value
    Market Cap 7.55 Million
    Num Shares 10.3 Million
    EPS -1.66
    Price-to-Earnings (P/E) Ratio -0.44
    Price-to-Sales 5.42
    Price-to-Book 5.02
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.85
    Resistance 3 (R3) 0.84 0.80 0.83
    Resistance 2 (R2) 0.80 0.76 0.80 0.82
    Resistance 1 (R1) 0.76 0.75 0.77 0.77 0.82
    Pivot Point 0.72 0.72 0.72 0.72 0.72
    Support 1 (S1) 0.68 0.68 0.69 0.69 0.64
    Support 2 (S2) 0.64 0.67 0.64 0.64
    Support 3 (S3) 0.60 0.64 0.63
    Support 4 (S4) 0.61